Unlock Biotech Royalty Investing
Access a new opportunity to invest in biotech through fractional royalty rights—an asset class historically reserved for large institutions. Support real therapies and earn returns tied to top-line drug revenue.

Support the Science You Believe In
Turn your belief in medicine into ownership. Back promising therapies and research from universities, biotech firms, and scientists, helping them fund development while you share in the upside.

Insulated from Dilution and Legal Exposure
Royalty investors are not affected by equity dilution from future fundraises or value erosion caused by company-specific lawsuits. Your returns are tied to revenue—not corporate balance sheets or legal uncertainties.

Earn Passive Income
Generate potential recurring income from the sale of approved therapies, with less volatility than equity and no exposure to R&D burn. Invest in royalties and get paid from real-world drug performance.

A Trusted and Compliant Platform
Built with experienced securities lawyers, broker-dealer partners, and regulatory infrastructure, BioPalace ensures secure investing through JOBS Act exemptions, secondary trading access, and transparent deal flow.